Omega Therapeutics Banner Image

Omega Therapeutics

  • Ticker OMGA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Omega Therapeutics Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Their OMEGA platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables controlMore of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega’s engineered, modular, and programmable mRNA medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of mapped and validated novel DNA-sequence-based epigenomic loci to durably tune single or multiple genes to treat and cure disease through unprecedented precision epigenomic control. Omega has a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.
Omega Therapeutics

Most Recent Annual Report

Omega Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Omega Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!